Articles of the Month
Videos
Articles
Successful usage of a chatbot to standardize and automate history taking in Hymenoptera venom allergy.
Schneider, S., Gasteiger, C., Wecker, et al. Allergy. First published: 22 March 2023
Atopic dermatitis: correlation of distinct risk factors with age of onset in adulthood compared to childhood
Maintz, L., Schmitz, M.-T., Herrmann, N., et al. Allergy. First published: 22 March 2023
Trait profiles in difficult-to-treat asthma: clinical impact and response to systematic assessment
Lin, T., Jonathan, P., Denton, E., et al. Allergy. First published: 20 March 2023
Dupilumab-associated ocular surface disease in atopic dermatitis patients: clinical characteristics, ophthalmic treatment response, and conjunctival goblet cell analysis
Achten, R., Thijs, J., van der Wal, M., et al. Allergy. First published: 19 March 2023
Legends of Allergy: Gianni Marone
Triggiani, M., Casolaro, V. and Stellato, C. Allergy. First published: 19 March 2023
Global Initiative for Asthma (GINA): 30 years of promoting evidence-based asthma care
Yorgancıoğlu, A., Reddel, H.K. Allergy. First published: 18 March 2023
Comparative effectiveness of Anti-IL5 and Anti-IgE biologic classes in patients with severe asthma eligible for both
Pfeffer, P.E., Ali, N., Murray, R., et al. Allergy. First published: 17 March 2023
Severe and refractory anaphylaxis in paediatric intensive care unit
Pouessel, G., Trochu, C., Chagnon, F., et al. Allergy. First published: 17 March 2023
Proinflammatory polarization of monocytes by particulate air pollutants is mediated by induction of trained immunity in pediatric asthma
Movassagh, H, Prunicki, M, Kaushik, A, et al. Allergy. First published: 16 March 2023
Prescribing patterns of budesonide/formoterol maintenance and reliever therapy in patients with asthma in Sweden
Janson, C., Melén, E., Licht, S.d.F., et al. Allergy. First published: 15 March 2023
pH sensing shapes immune cell function: The role of GPR65 and its implications for allergic disease
de Souza Ferreira, S., Bek, M.K. and Tibbitt, C.A. Allergy. First published: 14 March 2023
Immune Response Evolution in Peanut Epicutaneous Immunotherapy for Peanut-Allergic Children
Bastin, M., Carr, W.W., Davis, C.M., et al. Allergy. First published: 14 March 2023
PM2.5 chemical constituents and allergic rhinitis: Findings from a prospective cohort study in China
Jia, P., Feng, C., Ye, T., Shao, Y. and Yang, S. Allergy. First published: 11 March 2023
Quantitative analysis of urinary cytokines in food-allergic and healthy individuals
Lee, A.S., Parsons, E.S., Chang, I., et al. Allergy. First published: 11 March 2023
Multiple comparisons and effect size - statistical recommendations for authors planning to submit an article to Allergy
Ordak, M. Allergy. First published: 08 March 2023
An alternative path to oral tolerance
Li, C.H., Kabak, E. and Eiwegger, T. Allergy. First published: 08 March 2023
Acute and Chronic Impacts of Heat Stress on Planetary Health
Sampath, V., Shalakhti, O., Veidis, E., et al. Allergy. First published: 08 March 2023
Dupilumab treatment increases transitional B cells in severe asthma
Lommatzsch, M., Dost, M., Jaishankar, N., et al. Allergy. First published: 08 March 2023
The next generation virus-like particle platform for the treatment of peanut allergy
Sobczak, J.M., Krenger, P.S., Storni, F., et al. Allergy. First published: 08 March 2023
IL-4 drastically decreases deuterosomal and multiciliated cells via alteration in progenitor cell differentiation
Cho, H-J, Chung, YW, Moon, S, et al. Allergy. First published: 08 March 2023
Microglia–neuron interactions promote chronic itch via the NLRP3-IL-1β-GRPR axis
Liu, X, Wang, Y, Zeng, Y, et al. Allergy. First published: 06 March 2023
Determinants of bone density in children with immunoglobulin E-mediated food allergy
Nichols-Vinueza, D.X., Mateja, A., Hatzimemos, A., et al. Allergy. First published: 05 March 2023
IL-21 boosts germinal center response through independent actions on T and B cells in a concentration-dependent manner
Waldetario, M.C.G.M. Allergy. First published: 05 March 2023
Detection of gut and mucosal peptides through TOMAHAQ in healthy individuals
Parsons, E.S., Liu, F., Kaushik, A., et al. Allergy. First published: 05 March 2023
Factors associated with suboptimal response to monoclonal antibodies in severe asthma
Pérez de Llano, L., Marina Malanda, N., Urrutia, I., et al. Allergy. First published: 03 March 2023
In vivo and ex vivo inflammatory responses of the esophageal mucosa to food challenge in adults with eosinophilic esophagitis
Haasnoot, M.L., Kleuskens, M.T.A., Lopez-Rincon, A., et al. Allergy. First published: 03 March 2023
BTEX exposure and its body burden pose differential risks for asthma and its phenotypic clusters
Hsu, Y.-T., Wu, C.-C., Wang, C.-C., et al. Allergy. First published: 28 February 2023
Adult asthma with symptomatic eosinophilic inflammation is accompanied by alteration in gut microbiome
Gu, B.-H., Choi, J.-P., Park, T., et al. Allergy. First published: 27 February 2023
A molecular sensitization map of European children reveals exposome- and climate-dependent sensitization profiles
Kiewiet, M.B.G., Lupinek, C., Vrtala, S., et al. Allergy. First published: 23 February 2023
Effects of topical corticosteroid vs. tacrolimus on insulin sensitivity and bone homeostasis in adults with atopic dermatitis – a randomized controlled study
Gether, L., Storgaard, H., Kezic, S., et al. Allergy. First published: 23 February 2023
Induction of immunosuppressive CD39 but not the trafficking C-C chemokine receptor 4 on Treg during LAR in mite allergic asthma
Doyen, V., Poirot, A., Maumy-Bertrand, M., et al. Allergy. First published: 22 February 2023
Early increase in serum specific IgG2 upon allergen immunotherapy with a 300 IR sublingual house dust mite tablet
Berjont, N., Bordas-Le Floch, V., O’Hehir, R.E., et al. Allergy. First published: 21 February 2023
The immune-supportive diet in allergy management. A narrative review and proposal
Vlieg-Boerstra, B., Groetch, M., Vassilopoulou, E., et al. Allergy. First published: 21 February 2023
Citations: 86
The role of peripheral blood eosinophil counts in COVID-19 patients
Xie, G, Ding, F, Han, L, Yin, D, Lu, H, Zhang, M. Allergy. 2021; 76: 471– 482
Citations: 66
The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria
Zuberbier, T, Abdul Latiff, AH, Abuzakouk, M, Aquilina, S, Asero, R, Baker, D, et al. Allergy. 2022; 77: 734– 766
Citations: 66
EAACI statement on the diagnosis, management and prevention of severe allergic reactions to COVID-19 vaccines
Sokolowska, M., Eiwegger, T., Ollert, M., Torres, M.J., Barber, D., Del Giacco, S., et al. Allergy. 2021; 76: 1629-1639
Citations: 66
COVID-19 pandemic: Practical considerations on the organization of an allergy clinic—An EAACI/ARIA Position Paper
Pfaar, O, Klimek, L, Jutel, M, Akdis, C, A, Bousquet, J, Breiteneder, H, et al. Allergy. 2021; 76: 648– 676
Citations: 64
ARIA-EAACI statement on severe allergic reactions to COVID-19 vaccines – An EAACI-ARIA Position Paper
Klimek, L., Jutel, M., Akdis, C.A., Bousquet, J., Akdis, M., Torres, M.J., et al. Allergy. 2021; 76: 1624-1628
Citations: 58
Allergic reactions to the first COVID-19 vaccine: A potential role of polyethylene glycol?
Cabanillas, B., Akdis, C.A. and Novak, N. Allergy. 2021; 76: 1617-1618
Citations: 53
Allergenic components of the mRNA-1273 vaccine for COVID-19: Possible involvement of polyethylene glycol and IgG-mediated complement activation
Klimek, L., Novak, N., Cabanillas, B., Jutel, M., Bousquet, J. and Akdis, C.A. Allergy. 2021; 76: 3307-3313
Citations: 41
EAACI guidelines: Anaphylaxis (2021 update)
Muraro, A, Worm, M, Alviani, C, Cardona, V, DunnGalvin, A, Garvey, L, H, et al et al. Allergy. 2022; 2022; 77: 357– 377
Citations: 41
Vaccines and allergic reactions: The past, the current COVID-19 pandemic, and future perspectives
Sampath, V., Rabinowitz, G., Shah, M., Jain, S., Diamant, Z., Jesenak, M., et al. Allergy. 2021; 76: 1640-1660
Citations: 38
Childhood asthma outcomes during the COVID-19 pandemic: Findings from the PeARL multi-national cohort
Papadopoulos, N.G., Mathioudakis, A.G., Custovic, A., Deschildre, A., Phipatanakul, W., Wong, G., et al. Allergy. 2021; 76: 1765-1775
Citations: 35
Anaphylaxis to the first dose of mRNA SARS-CoV-2 vaccines: Don't give up on the second dose!
Krantz, M.S., Bruusgaard-Mouritsen, M.A., Koo, G., Phillips, E.J., Stone, C.A., Jr and Garvey, L.H. Allergy. 2021; 76: 2916-2920
Citations: 35
Efficacy and safety of treatment with biologicals for severe chronic rhinosinusitis with nasal polyps: A systematic review for the EAACI guidelines
Agache, I., Song, Y., Alonso-Coello, P., Vogel, Y., Rocha, C., Solà, I., et al. Allergy. 2021; 76: 2337-2353
Citations: 34
In vitro data suggest that Indian delta variant B.1.617 of SARS-CoV-2 escapes neutralization by both receptor affinity and immune evasion
Augusto, G, Mohsen, MO, Zinkhan, S, Liu, X, Vogel, M, Bachmann, MF. Allergy. 2022; 77: 111– 117
Citations: 33
Basophil activation test: Mechanisms and considerations for use in clinical trials and clinical practice
Santos, A.F., Alpan, O. and Hoffmann, H.-J. Allergy. 2021; 76: 2420-2432
Citations: 32
Profound dysregulation of T cell homeostasis and function in patients with severe COVID-19
Adamo, S., Chevrier, S., Cervia, C., Zurbuchen, Y., Raeber, M.E., Yang, L., et al. Allergy. 2021; 76: 2866-2881
Citations: 32
Practice parameters for diagnosing and managing iodinated contrast media hypersensitivity
Torres, MJ, Trautmann, A, Böhm, I, Scherer, K, Barbaud, A, Bavbek, S, et al. Allergy. 2021; 76: 1325– 1339
Citations: 31
The role of allergen-specific IgE, IgG and IgA in allergic disease
Shamji, MH, Valenta, R, Jardetzky, T, Verhasselt, V, Durham, S, R, Würtzen, P, A, et al. Allergy. 2021; 76: 3627– 3641
Citations: 30
Elastase and exacerbation of neutrophil innate immunity are involved in multi-visceral manifestations of COVID-19
Guéant, J.-L., Guéant-Rodriguez, R.-M., Fromonot, J., Oussalah, A., Louis, H., Chery, C., et al. Allergy. 2021; 76: 1846-1858
The second COVID-19 mRNA vaccine dose enhances the capacity of Spike-specific memory B cells to bind Omicron BA.2
Hartley, G.E., Edwards, E.S.J., Varese, N., et al. Allergy. First published: 21 December 2022
National trends in the prevalence of allergic diseases among Korean adolescents before and during COVID-19, 2009-2021: A serial analysis of the national representative study
Koo, M.J., Kwon, R., Lee, S.W., et al. Allergy. First published: 28 November 2022
Recent developments in the immunopathology of COVID-19
Zhang, H.-p., Sun, Y.-l., Wang, Y.-f., et al. Allergy. First published: 24 November 2022
Immediate hypersensitivity reactions to anti-SARS-CoV-2 neutralizing monoclonal antibodies: a real-life experience
Franceschini, L. and Farsi, A. Allergy. First published: 16 November 2022
Diagnostic accuracy of vaccine and vaccine excpient testing in the setting of allergic reactions to covid-19 vaccines: a systematic review and meta-analysis
Greenhawt, M., Shaker, M., Golden, D.B.K., et al. Allergy. First published: 02 November 2022
The impact of dupilumab treatment on SARS-CoV-2 T cell responses in atopic dermatitis patients
Ungar, B., Hartzell, S., Lozano-Ojalvo, D., et al. Allergy. First published: 01 October 2022
Implementation of the web-based calculator estimating odds ratio of severe COVID-19 for unvaccinated individuals in a country with high coronavirus-related death toll
Kwasniewski, M., Korotko, U., Chwialkowska, K., et al. Allergy. First published: 21 September 2022
Disproportionate rate of female referrals for suspected COVID-19 vaccine allergies
Chiang, V., Kan, A.K.C., Yim, J.S.H., et al. Allergy. First published: 20 September 2022
Drug hypersensitivity, in vitro tools, biomarkers, and burden with COVID-19 vaccines
Palomares, F., Paris, J.L., Labella, M., Doña, I., Mayorga, C. and Torres, M.J. Allergy. First published: 01 August 2022
SARS-CoV-2 infection in severe asthma is associated with worsening of COVID-19 through respiratory NLRP3 inflammasome activation
Jeong, J.S., Choi, J.Y., Kim, J.S., et al. Allergy. First published: 24 July 2022
Exposure to avian coronavirus vaccines is associated with increased levels of SARS-CoV-2-cross-reactive antibodies
Ardicli, O, Carli, KT, Satitsuksanoa, P, et al. et al. Allergy. First published: 23 July 2022
Urticaria and/or angioedema secondary to mRNA COVID-19 vaccines: Updates from a United States case registry
Anvari, S., Samarakoon, U., Fu, X., et al. Allergy. First published: 16 July 2022
The nasopharyngeal and salivary microbiomes in COVID-19 patients with and without asthma
Kim, J.G., Zhang, A., Rauseo, A.M., et al. Allergy. First published: 15 July 2022
Management of suspected and confirmed COVID-19 (SARS-CoV-2) vaccine hypersensitivity
Worm, M., Alexiou, A., Bauer, A., et al. Allergy. First published: 20 June 2022
Presentation of airway and general symptoms in COVID-19 caused by dominant SARS-CoV-2 variants: a follow-up on ARIA consensus
et al. Allergy. First published: 14 June 2022
Immune-inflammatory proteome of elite ice hockey players before and after SARS-CoV-2 infection
Maurer, D.J., Barletta, E., Heider, A., et al. Allergy. First published: 12 June 2022
Combined assessment of S- and N-specific IL-2 and IL-13 secretion and CD69 neo-expression for discrimination of post–infection and post-vaccination cellular SARS-CoV-2-specific immune response
Kratzer, B., Schlax, L.C., Gattinger, P., et al. Allergy. First published: 12 June 2022
T cell recovery and evidence of persistent immune activation 12 months after severe COVID-19
Taeschler, P., Adamo, S., Deng, Y., et al. Allergy. First published: 14 May 2022
Long-term effects of homologous and heterologous SARS-CoV-2 vaccination on humoral and cellular immune responses
Hollstein, M.M., Münsterkötter, L., Schön, M.P., et al. Allergy. First published: 14 May 2022
COVID-19 in the absence of eosinophils: The outcome of confirmed SARS-CoV-2 infection whilst on treatment with benralizumab
Francis, C.H.R., Hearn, A.P., Ratnakumar, S., et al. Allergy. First published: 01 May 2022
Effect of BTN162b2 and Coronavac boosters on humoral and cellular immunity of individuals previously fully vaccinated with Coronavac against SARS-CoV-2: A longitudinal study
Kuloğlu, Z.E., El, R., Guney-Esken, et al. Allergy. First published: 19 April 2022
Intranasal administration of a VLP-based vaccine induces neutralizing antibodies against SARS-CoV-2 and variants of concern
Rothen, D.A., Krenger, P.S., Nonic, A., et al. Allergy. First published: 11 April 2022
Autoantibodies in COVID-19 correlate with anti-viral humoral responses and distinct immune signatures
Taeschler, P., Cervia, C., Zurbuchen, Y., et al. Allergy. First published: 01 April 2022
Vaccine based on folded RBD-PreS fusion protein with potential to induce sterilizing immunity to SARS-CoV-2 variants
Gattinger, P., Kratzer, B., Tulaeva, I., et al. Allergy. First published: 31 March 2022
Are health care policies for COVID-19 evidence-based?
Bonini, S. and Fiorito, S. Allergy. First published: 30 March 2022
Virus-related stimuli modulate SARS-CoV-2 entry factor expression in pediatric tonsillar epithelial cells in vitro
Hara, M., Morimoto, N., Watabe, T., et al. Allergy. First published: 29 March 2022
Do basophil activation tests help elucidate allergic reactions to the ingredients in COVID-19 vaccines?
Eberlein, B., Sonja, M., Fischer, J., Darsow, U., Biedermann, T. and Brockow, K. Allergy. First published: 10 March 2022
Humoral immune response of Sinopharm/BBIBP COVID-19 vaccination before and after the booster immunization
Cheng, Z.J., Huang, H., Zheng, P., et al. Allergy. First published: 07 March 2022
February 2023 - Food Allergy and Allergic/Inflammatory Gastrointestinal Diseases
Volume 78 | Issue 2
The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria
Zuberbier, T, Abdul Latiff, AH, Abuzakouk, M, et al. Allergy. 2022; 77: 734– 766
The EAACI/GA2LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria
Zuberbier, T., Aberer, W., Asero, R., Abdul Latiff, A., H., Baker, D., Ballmer-Weber, B. et al. Allergy. 2018; 73: 1393- 1414
Risk factors for severe and critically ill COVID-19 patients: A review
Gao, Y-D, Ding, M, Dong, X, et al. Allergy. 2021; 76: 428– 455
Vaccines and allergic reactions: the past, the current COVID-19 pandemic, and future perspectives
Sampath, V., Rabinowitz, G., Shah, M., Jain, S., Diamant, Z., Jesenak, M. et al. Allergy. 2021; 76: 1640-1660
Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19
Azkur, A.,K., Akdis, M., Azkur, D., Sokolowska, M., van de Veen, W., Brüggen, M.,C. et al. Allergy. 2020; 75: 1564– 1581
EAACI guidelines: Anaphylaxis (2021 update)
Muraro, A, Worm, M, Alviani, C, et al. Allergy. 2022; 77: 357– 377
Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen)
Bousquet, J., Khaltaev, N., Cruz, A.A., Denburg, J., Fokkens, W.J., Togias, A. et al. Allergy. 2008; 63: 8-160
Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China
Zhang, J.-J., Dong, X., Cao, Y.-Y., Yuan, Y.-D., Yan, Y.-Q., Akdis, C., A. and Gao, Y.-D. Allergy. 2020; 75: 1730– 1741
Advances and recent developments in asthma in 2020
Cevhertas, L, Ogulur, I, Maurer, DJ, et al. Allergy. 2020; 75: 3124– 3146
The international WAO/EAACI guideline for the management of hereditary angioedema – the 2021 revision and update
Maurer, M., Magerl, M., Betschel, S., et al. Allergy. First published: 10 January 2022
A compendium answering 150 questions on COVID-19 and SARS-CoV-2
Riggioni, C., Comberiati, P., Giovannini, M., Agache, I., Akdis, M., Alves-Correia, M. et al. Allergy. 2020; 75: 2503– 2541
Special Issue: Perspectives in Allergen Immunotherapy: 2019 and Beyond
Volume 74 | Issue S108
Management of anaphylaxis due to COVID-19 vaccines in the elderly
Bousquet, J., Agache, I., Blain, H., et al. Allergy. 2021; 76: 2952-2964
Predictors of treatment response in chronic spontaneous urticaria
Fok, J.S., Kolkhir, P., Church, M.K. and Maurer, M. Allergy. 2021; 76: 2965-2981
Interleukin-31: The “itchy” cytokine in inflammation and therapy
Datsi, A., Steinhoff, M., Ahmad, F., Alam, M. and Buddenkotte, J. Allergy. 2021; 76: 2982-2997
Markers for the involvement of endothelial cells and the coagulation system in chronic urticaria: A systematic review
Mostmans, Y., De Smedt, K., Richert, B., et al. Allergy. 2021; 76: 2998-3016
Eczema herpeticum in atopic dermatitis
Traidl, S., Roesner, L., Zeitvogel, J. and Werfel, T. Allergy. 2021; 76: 3017-3027
CytoBas: Precision component-resolved diagnostics for allergy using flow cytometric staining of basophils with recombinant allergen tetramers
McKenzie, C.I., Varese, N., Aui, P.M., et al. Allergy. 2021; 76: 3028-3040
Heterogeneity of pollen food allergy syndrome in seven Southern European countries: The @IT.2020 multicenter study
Lipp, T, Acar Şahin, A, Aggelidis, X, et al. Allergy. 2021; 76: 3041– 3052
Direct assessment of individual skin barrier components by electrical impedance spectroscopy
Mannweiler, R., Bergmann, S., Vidal-y-Sy, S., Brandner, J.M. and Günzel, D. Allergy. 2021; 76: 3094-3106
Prenatal paraben exposure and atopic dermatitis-related outcomes among children
Thürmann, L, Herberth, G, Seiwert, B, et al. Allergy. 2021; 76: 3122– 3132
Free human DNA attenuates the activity of antimicrobial peptides in atopic dermatitis
Kopfnagel, V, Dreyer, S, Zeitvogel, J, et al. Allergy. 2021; 76: 3145– 3154
Nanoarchitectures for efficient IgE cross-linking on effector cells to study amoxicillin allergy
Tesfaye, A., Rodríguez-Nogales, A., Benedé, S., et al. Allergy. 2021; 76: 3183-3193
Sweet syndrome induced by SARS-CoV-2 Pfizer-BioNTech mRNA vaccine
Darrigade, A.-S., Théophile, H., Sanchez-Pena, P., et al. Allergy. 2021; 76: 3194-3196
Transgenic mice overexpressing the PGE2 receptor EP2 on mast cells exhibit a protective phenotype in a model of allergic asthma
Urbano, A., Plaza, J., Turon, S., et al. Allergy. 2021; 76: 3196-3199
Type 2 biomarker expression (FeNO and blood eosinophils) is higher in severe adult-onset than in severe early-onset asthma
Lommatzsch, M., Klein, M., Stoll, P. and Virchow, J.C. Allergy. 2021; 76: 3199-3202
Identification of Ulocladium chartarum as an important indoor allergen source
Pfeiffer, S., Sandler, P., Raith, M., et al. Allergy. 2021; 76: 3202-3206
Effects of allergen immunotherapy in the MASK-air study: a proof-of-concept analysis
Pfaar, O., Sousa-Pinto, B., Devillier, P., et al. Allergy. 2021; 76: 3212-3214
Predicted number of peanut-allergic patients needed to treat with epicutaneous immunotherapy (EPIT) to prevent one allergic reaction: A novel approach to assessing relevance
Remington, B.C., Koppelman, S.J., Green, T.D., et al. Allergy. 2021; 76: 3223-3226
Legends of allergy and immunology: Sergio Bonini
Maltese, G. and Rasi, G. Allergy. 2021; 76: 3227-3229
Medical algorithm: Peri-operative management of mastocytosis patients
Bocca-Tjeertes, I.F.A., van de Ven, A.A.J.M., Koppelman, G.H., et al. Allergy. 2021; 76: 3233-3235
Open Access Agreements with Wiley
Check here if your research institution has an agreement with Wiley to make your Original Articles and Review Articles free to read, download and share by everyone: Institutional Payments | Wiley
17th World Immune Regulation Meeting
As ever, immune regulation is the hottest issue in basic and clinical sciences. With an outstanding list of speakers in this field, WIRM will be one of the key scientific event of the year 2023, being big enough to learn from other disciplines and small enough to personally meet the experts. Check out the website for more information by clicking here.
Junior Members Corner
Dear Junior Members,
The EAACI Winter School 2023 has been a great success! This year, on the occasion of the 20th anniversary of the meeting, it was held in Davos, Switzerland, the place where it was first held!
During 4 exciting days (26-29 January 2023), 70 Junior Members from all over the world had the opportunity to share their innovative results related to allergy and Immunology. For the first time, the meeting had an innovative format. On the first day, we enjoyed inspiring talks by Liam O'Mahony, Oscar Palomares, Mary Prunicki and Sirpa Pietikainen. You can see again these talks at the EAACI Knowledge Hub.
We also enjoyed the 6 keynote lectures by leading experts in their fields, the 20 oral presentations by Junior Members with a wide variety of topics and the 48 poster presentations, where we were able to discuss a lot about our studies and results, with inspiring interaction with faculties and with other Juniors. The experience was very enriching, and our research has certainly improved a lot.
In addition, we had the opportunity to visit the Swiss Institute for Allergy and Asthma Research (SIAF). There, we see the facilities and equipment on confocal microscopy, flow cytometry, classification, mass spectrometry... explained by SIAF members. Moreover, we can work in small groups during workshop sessions to discuss about what we already know and unmet needs in relation to Environment and Immunology. After the discussions, on the last day, each group presented its conclusions to all participants, and the outcome of these workshops was a total success!
We cannot forget to mention the networking activities and the important interaction between the participants during breakfast, lunch, and dinner, characteristic of this meeting.
The Winter School was a great success! We hope to see you again next year in Zakopane (Poland).
Best regards,
The Junior Member Assembly
